Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis
- Arroyo, R.
- Bury, D.P.
- Guo, J.D.
- Margolin, D.H.
- Melanson, M.
- Daizadeh, N.
- Cella, D.
ISSN: 1477-0970, 1352-4585
Argitalpen urtea: 2020
Alea: 26
Zenbakia: 8
Orrialdeak: 955-963
Mota: Artikulua